Evidence map›Paper›PMID 42165624›Full record

ArticleMicrobiology spectrum2026

Characterization and comparative genomic analysis of a novel bacteriophage against an extremely drug-resistant

Jie Jiang, Li Zhao, Chongzhi Cai, Liuyang Hu, Shuping Qin, Liang Liang, Yulin Yuan

Abstract read
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jie JiangDepartment of Clinical Laboratory, the People's Hospital of Guangxi Zhuang Autonomous Region (Guangxi Academy of Medical Science), Nanning, Guangxi, China.ORCID 0009-0006-9955-547X
Li ZhaoDepartment of Clinical Laboratory, the People's Hospital of Guangxi Zhuang Autonomous Region (Guangxi Academy of Medical Science), Nanning, Guangxi, China.
Chongzhi CaiDepartment of Clinical Laboratory, the People's Hospital of Guangxi Zhuang Autonomous Region (Guangxi Academy of Medical Science), Nanning, Guangxi, China.
Liuyang HuDepartment of Clinical Laboratory, the People's Hospital of Guangxi Zhuang Autonomous Region (Guangxi Academy of Medical Science), Nanning, Guangxi, China.ORCID 0000-0002-9309-6448
Shuping QinDepartment of Clinical Laboratory, the People's Hospital of Guangxi Zhuang Autonomous Region (Guangxi Academy of Medical Science), Nanning, Guangxi, China.
Liang LiangDepartment of Clinical Laboratory, the People's Hospital of Guangxi Zhuang Autonomous Region (Guangxi Academy of Medical Science), Nanning, Guangxi, China.
Yulin YuanDepartment of Clinical Laboratory, the People's Hospital of Guangxi Zhuang Autonomous Region (Guangxi Academy of Medical Science), Nanning, Guangxi, China.ORCID 0000-0003-0393-7475

Funding

Central Government Guidance Fund for Local Science and Techonology Development of Guangxi Zhuang Autonomous Region ZY2412050Guangxi Natural Science Foundation 2023GXNSFBA026028
6 · The paper itself

Abstract

Given the rising prevalence of multidrug-resistant strains, IMPORTANCE: This study isolated a novel phage, CRPAP1904, from the hospital's sewage that specifically targets an extremely drug-resistant

Indexed as

Pseudomonas aeruginosaPseudomonas PhagesAnti-Bacterial AgentsBase CompositionDrug Resistance, Multiple, BacterialGenome, ViralGenomicsHost SpecificityOpen Reading FramesPhylogenyAnti-Bacterial Agentsmultidrug-resistantphagePseudomonas aeruginosaST1971

Identifiers

PMID42165624
PMCPMC13340246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.